No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration

Marion Schroeder1 Division of Ophthalmology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, LundCorrespondence[email protected]

Lena Rung2 Department of Ophthalmology, Helsingborg Hospital, Helsingborg, Sweden

Monica Lövestam-Adrian1 Division of Ophthalmology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund

Pages 1105-1111 | Published online: 09 Jun 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KlaverCCWolfsRCVingerlingJRHofmanAde JongPTAge-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam studyArch Ophthalmol199811656536589596502
PubMed Web of Science ®Google Scholar
RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
PubMed Web of Science ®Google Scholar
BrownDMMichelsMKaiserPKHeierJSSyJPIanchulevTANCHOR Study GroupRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR studyOphthalmology200911615765.e519118696
PubMed Web of Science ®Google Scholar
HeierJSBrownDMChongVVIEW 1 and VIEW 2 Study GroupsIntravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationOphthalmology2012119122537254823084240
PubMed Web of Science ®Google Scholar
SingerMAAwhCCSaddaSHORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degenerationOphthalmology201211961175118322306121
PubMed Web of Science ®Google Scholar
HolzFGAmoakuWDonateJSUSTAIN Study GroupSafety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN studyOphthalmology2011118466367121459217
PubMed Web of Science ®Google Scholar
HolzFGTadayoniRBeattySMulti-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationBr J Ophthalmol201599222022625193672
PubMed Web of Science ®Google Scholar
OrrPRentzAMMargolisMKValidation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degenerationInvest Ophthalmol Vis Sci20115263354335921282568
PubMed Web of Science ®Google Scholar
SuñerIJKokameGTYuEWardJDolanCBresslerNMResponsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trialsInvest Ophthalmol Vis Sci20095083629363519255158
PubMed Web of Science ®Google Scholar
BresslerNMChangTSSuñerIJMARINA and ANCHOR Research GroupsVision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOROphthalmology20101174747756.e420189654
PubMed Web of Science ®Google Scholar
RungLLövestam-AdrianMThree-year follow-up of visual outcome and quality of life in patients with age-related macular degenerationClin Ophthalmol2013739540123467557
PubMedGoogle Scholar
SouiedEHOubrahamHMimounGCohenSYQuereSDerveloyATWIN Study GroupChanges in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the TWIN studyRetina20153591743174925901835
PubMed Web of Science ®Google Scholar
WolfAKampikAEfficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services researchGraefes Arch Clin Exp Ophthalmol2014252464765524424409
PubMed Web of Science ®Google Scholar
Boulanger-ScemamaESayagDHa Chau TranTRanibizumab et dégénérescence maculaire liée à l’âge exsudative: analyse multicentrique à 5 ans des résultats fonctionnels et anatomiques en pratique clinique réelle. [Ranibizumab and exudative age-related macular degeneration: 5-year multicentric functional and anatomical results in real-life practice]J Fr Ophtalmol2016398668674 French [with English abstract]27609025
PubMed Web of Science ®Google Scholar
BhisitkulRBMendesTSRofaghaSMacular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP studyAm J Ophthalmol20151595915924.e225640411
PubMed Web of Science ®Google Scholar
RasmussenABrandiSFuchsJVisual outcomes in relation to time to treatment in neovascular age-related macular degenerationActa Ophthalmol201593761662026073051
PubMed Web of Science ®Google Scholar
MitchellJBradleyCQuality of life in age-related macular degeneration: a review of the literatureHealth Qual Life Outcomes200649717184527
PubMed Web of Science ®Google Scholar
ChangTSBresslerNMFineJTDolanCMWardJKlesertTRMARINA Study GroupImproved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trialArch Ophthalmol2007125111460146917998507
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date